Safe Harbor Statement

10/7/2002


Click here to start


Table of Contents

PPT Slide

Safe Harbor Statement

PPT Slide

PPT Slide

Nanogen Chronology

Three-year Commercialization Plan

Molecular Diagnostic Focus

Why Molecular Diagnostics?

Discovery Effort Driving Market Growth

Molecular Diagnostics Market Today

Molecular Diagnostics Market Today

Market Readiness – Tip of the Iceberg

PPT Slide

Value Capturing Platform

Three-year Commercialization Plan

2001 – Focus on Molecular Diagnostics

2001 – The Management Team

Three-year Commercialization Plan

2002 - Nanogen Platformation

2002 – Nanogen Platformation

PPT Slide

PPT Slide

2002 - Nanogen Platformation

2002 – Fulfilling the Promise with Cystic Fibrosis

2002 - Software Serves Two Customers

On-Screen Instructions Guide User Through The Process

2002 – Nanogen Menu Expansion

2002 – Summary Through Q3

Three-year Commercialization Plan

2003 - Clinical Lab “Buy” Criteria

2003 – Clinical Lab “Value Proposition”

2003 - Increasing Revenue Capture

2003 – Clinical Lab “Value Proposition”

2003 - Increasing the Installed Base

2003 - Development Path

2003 – Why Nanogen Will Win!

PPT Slide

Platform Technology

PPT Slide

2002 Milestones

Investment Rationale

PPT Slide

Author: dehaan